State Street Corporation 13D and 13G filings for Kymera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-23 10:31 am Sale | 2023-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | STATE STREET CORP STT | 1,894,279 3.410% | -951,942 (-33.45%) | Filing |
| 2023-02-08 2:16 pm Purchase | 2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | STATE STREET CORP STT | 2,846,221 5.190% | 2,846,221 (New Position) | Filing |